This major award is a great achievement for Allan and a boost for his team of scientists enabling the further understanding of molecular mechanisms in pulmonary arterial hypertension to aid the continued translation of novel therapies for patient benefit.
Continuing the Fight for Answers to PAH (Pulmonary Artery Hypertension)
